ClinicalTrials.gov
ClinicalTrials.gov Menu

Thiamine and Acute Decompensated Heart Failure: Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00680706
Recruitment Status : Completed
First Posted : May 20, 2008
Results First Posted : September 28, 2012
Last Update Posted : August 21, 2013
Sponsor:
Collaborator:
Beth Israel Deaconess Medical Center
Information provided by (Responsible Party):
Howard Smithline, Baystate Medical Center

Brief Summary:

Heart failure remains an increasing cause of morbidity and mortality in the United States even in the face of recent advances in the treatment of cardiovascular disease. There is an urgent need to reevaluate the treatment of heart failure. Shifting substrate utilization used in energy metabolism from fatty acids to glucose is beneficial to the heart presumably by increasing the efficiency of ATP production. Several new drugs for the treatment of cardiac ischemia work by this mechanism. There is increasing evidence that patients with heart failure may also benefit by the same type of intervention. Patients with heart failure are known to have low serum thiamine levels because of poor dietary intake and increased urinary excretion. Inadequate thiamine will deleteriously shift substrate utilization from glucose to fatty acids.

We hypothesize that thiamine supplementation will be beneficial for patients with heart failure by increasing glucose and decreasing fatty acid utilization. This will be initially tested in a pilot double-blinded placebo controlled study of thiamine supplementation in diabetic and non-diabetic patients presenting to the emergency department with acute decompensated heart failure.


Condition or disease Intervention/treatment Phase
Heart Failure Diabetes Drug: Thiamine Drug: Placebo Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 131 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Targeting Myocardial Energy Metabolism for the Treatment of Acute Heart Failure: The Effect of Thiamine on Biochemical, Electrocardiographic and Respiratory Parameters in Hospitalized Patients.
Study Start Date : January 2008
Actual Primary Completion Date : February 2010
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Thiamine
Receives thiamine
Drug: Thiamine
Thiamine (100 mg) in 50 ml D5W, x 2.
Other Name: Vitamin B1
Placebo Comparator: Control Drug: Placebo
D5W (50 ml)



Primary Outcome Measures :
  1. Effect of Thiamine Supplementation on Dyspnea [ Time Frame: Baseline ]
    Sitting Upright on Oxygen. Measured using a 10-centimeter visual analog scale (VAS). Measures are in units of millimeters (mm). A smaller number should be interpreted as a less dyspnea. A larger number should be interpreted as a more dyspnea. Less dyspnea is a better clinical outcome than more dyspnea.

  2. Effect of Thiamine Supplementation on Dyspnea [ Time Frame: 8-Hour ]
    Sitting Upright on Oxygen. Measured using a 10-centimeter visual analog scale (VAS). Measures are in units of millimeters (mm). A smaller number should be interpreted as a less dyspnea. A larger number should be interpreted as a more dyspnea. Less dyspnea is a better clinical outcome than more dyspnea.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. History of heart failure on a loop diuretic.
  2. Worsening dyspnea over the past 24 hours.
  3. Currently dyspneic sitting or supine, on or off oxygen.
  4. Radiographic cephalization of vessels. This criteria is not needed if the patient has no other reason for being dyspneic after being evaluated in the emergency department.
  5. Elevated NT pro-BNP (>450).
  6. Able to communicate in English or Spanish.
  7. Able and willing to provide informed consent.
  8. Age > 18 years.
  9. A primary admitting diagnosis of acute decompensated heart failure.

Exclusion Criteria:

  1. Renal failure on dialysis.
  2. Severe valvular disease.
  3. EKG criteria for acute myocardial infarction (ST segment elevation > 1mm on two contiguous leads).
  4. Initial troponin elevated.
  5. Ventricular arrhythmia (ventricular tachycardia or fibrillation).
  6. Supraventricular arrhythmia (atrial fibrillation / flutter) with a ventricular rate >120 beats per minute.
  7. Taking a daily thiamine supplementation (any multivitamin or specific thiamine supplementation within the past 2 weeks. Fortified foods, such as cereals, are acceptable
  8. Taking a daily fatty acid supplement.
  9. Pregnancy as determined by standard serum or urine b-HCG assay.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00680706


Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Baystate Medical Center
Springfield, Massachusetts, United States, 01199
Sponsors and Collaborators
Baystate Medical Center
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Howard Smithline, MD Baystate Medical Center

Responsible Party: Howard Smithline, Chief, Emergency Medicine Research, Baystate Medical Center
ClinicalTrials.gov Identifier: NCT00680706     History of Changes
Other Study ID Numbers: 07-059
First Posted: May 20, 2008    Key Record Dates
Results First Posted: September 28, 2012
Last Update Posted: August 21, 2013
Last Verified: August 2013

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases
Thiamine
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs